Patients who took a GLP-1 drug fared better than those in a control group at keeping their blood glucose levels in a healthy ...

The pharmaceutical company alleges Hims is widely selling cheaper versions of its blockbuster drugs, despite the FDA's recent ...

A GLP-1 in pill form from Eli Lilly shows promising results for weight loss and Type 2 diabetes treatment in a trial. FDA ...

An investigational injectable that only requires dosing once every 4 weeks led to substantial weight loss in patients with ...

A GLP-1 medication used to treat type 2 diabetes and obesity may help cut a person's monthly migraine days by about half, a ...

GLP-1 therapies primarily use single-use injectable pens, contributing to medical waste challenges. The pharmaceutical ...

Glucagon-Like-Peptide-1 Agonists, like Ozempic, have become extremely popular for weight loss. Here are some of the side ...

That is according to the findings of a study presented on Friday at the European Academy of Neurology congress. The pilot ...

Overweight patients given an experimental weight loss drug being developed by China's Sciwind Biosciences lost an average of ...

With semaglutide and tirzepatide dosed once weekly, their estimated average yearly costs in the U.S. are $14,080 and $8,126, ...

A new study reports that people taking GLP-1 drugs in daily life don’t lose as much weight as those in clinical trials who ...